The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has approved AstraZeneca's Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate or BGF ...
AstraZeneca’s Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate or BGF), already licensed for the treatment of chronic obstructive pulmonary disease ...
(RTTNews) - AstraZeneca Plc (AZN.L, AZN) said Trixeo Aerosphere has been approved in the European Union for maintenance treatment in adult patients with moderate to severe chronic obstructive ...
(Alliance News) - AstraZeneca PLC on Monday announced that its medicine Trixeo Aerosphere has been approved by the UK Medicines & Healthcare Products Regulatory Agency with "an innovative, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results